Iron Oxide Nanoparticles Functionalized with Fucoidan: a Potential Theranostic Nanotool for Hepatocellular Carcinoma.
Saved in:
| Title: | Iron Oxide Nanoparticles Functionalized with Fucoidan: a Potential Theranostic Nanotool for Hepatocellular Carcinoma. |
|---|---|
| Authors: | Geinguenaud F; Université Sorbonne Paris Nord and Université Paris Cité, INSERM, LVTS, 75018, Paris, France., Sainte-Catherine O; Université Sorbonne Paris Nord and Université Paris Cité, INSERM, LVTS, 75018, Paris, France., Poirier F; Université Sorbonne Paris Nord, Plateforme PPUP13, 93000, Bobigny, France., Besnard V; Université Sorbonne Paris Nord, H&P INSERM, UMR 1272, 93000, Bobigny, France., Haddad O; Université Sorbonne Paris Nord and Université Paris Cité, INSERM, LVTS, 75018, Paris, France., Chaubet F; Université Sorbonne Paris Nord and Université Paris Cité, INSERM, LVTS, 75018, Paris, France., Lalatonne Y; Université Sorbonne Paris Nord and Université Paris Cité, INSERM, LVTS, 75018, Paris, France.; Service de Biophysique et Médecine Nucléaire, AP-HP, Hôpital Avicenne, 9300, Bobigny, France., Lutomski D; Université Sorbonne Paris Nord, Plateforme PPUP13, 93000, Bobigny, France., Sutton A; Université Sorbonne Paris Nord and Université Paris Cité, INSERM, LVTS, 75018, Paris, France.; Service de Biochimie, AP-HP, Hôpital Jean Verdier, 93140, Bondy, France., Motte L; Université Sorbonne Paris Nord and Université Paris Cité, INSERM, LVTS, 75018, Paris, France. |
| Source: | Chembiochem : a European journal of chemical biology [Chembiochem] 2022 Aug 17; Vol. 23 (16), pp. e202200265. Date of Electronic Publication: 2022 Jul 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 100937360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-7633 (Electronic) Linking ISSN: 14394227 NLM ISO Abbreviation: Chembiochem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
